Halozyme Therapeutics
Price & Volume
Stats
See more52W Range | $61.23-$116.85 |
Market Cap | $12.6B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $1.6B |
Revenue Growth (YoY) | 47.7% |
Gross Profit (12 Mos) | $1.2B |
Diluted EPS | $3.42 |
News
See moreYahoo Finance • 6 days ago
Halozyme Therapeutics (HALO) Expands Argenx Deal, Is It Still 27% Below Fair Value?
Yahoo Finance • 6 days ago
Is Halozyme’s EU Injunction on Subcutaneous Keytruda Reshaping the Investment Case For Merck (MRK)?
Yahoo Finance • 7 days ago
Sector Update: Healthcare Stocks Rise in Afternoon Trading
Yahoo Finance • 7 days ago
Halozyme stock rises after winning injunction against Merck
About
CEO | Dr. Helen I. Torley M.B. Ch. B., M.R.C.P. |
CFO | Mr. Darren Snellgrove |
Address | 12390 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 423 |